Status:
COMPLETED
Pain Management Protocol for Pediatric Sickle Cell Disease
Lead Sponsor:
University of South Carolina
Collaborating Sponsors:
Pfizer
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
8-18 years
Brief Summary
Sickle cell disease (SCD) is a devastating chronic health condition that primarily affects African-Americans. Painful episodes are the most frequent form of morbidity in SCD and the most frequent reas...
Detailed Description
"Home-Based Pain Management Protocol for Children with Sickle Cell Disease" BACKGROUND: Sickle cell disease (SCD) is a devastating chronic health condition that primarily affects African-Americans. P...
Eligibility Criteria
Inclusion
- Inclusion criteria mandate that the families selected demonstrate adherence with standard SCD treatment as indicated by reliable attendance to clinic visits, and chart notes demonstrating adherence to prescribed medical care (e.g., follow-through with required specialist visits and appointments for diagnostic procedures). Participants must have had at least 1 major pain episode or 3 minor pain episodes in the previous 6 months that resulted in functional impairment, such as reduced school attendance.
Exclusion
- Individuals with developmental disabilities such as mental retardation, autism, and Down syndrome, severe cognitive limitations following stroke, or diagnoses of severe psychopathology will be excluded from participation as these disorders have the potential to confound the findings.
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00386048
Start Date
November 1 2006
End Date
August 1 2012
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Cancer and Blood Disorder
Columbia, South Carolina, United States, 29203